Literature DB >> 32970195

Relationship between the tumor location and clinicopathological features in left-sided pancreatic ductal adenocarcinoma.

Teijiro Hirashita1, Yukio Iwashita2, Atsuro Fujinaga2, Hiroaki Nakanuma2, Takashi Masuda2, Yuichi Endo2, Masayuki Ohta2, Masafumi Inomata2.   

Abstract

PURPOSE: Although the same distal pancreatectomy (DP) is performed regardless of the location of left-sided pancreatic ductal adenocarcinoma (PDAC), the clinicopathological features may differ depending on the tumor location. The present study investigated the relationship between the tumor location and clinicopathological features in patients with left-sided PDAC.
METHODS: The records of 59 patients who underwent DP for PDAC were enrolled. The relationship between the tumor location and clinicopathological features was investigated. The tumor location was classified into three groups according to the 7th AJCC/UICC TNM classification: body (Pb), body and tail (Pbt), and tail (Pt).
RESULTS: Tumors were located at the Pb in 26 patients, Pbt in 15, and Pt in 18. There was no metastasis to the lymph nodes around the common hepatic artery in Pt. The rate of peritoneal dissemination in the Pt was higher than that in the Pb (P = 0.034) or Pbt (P = 0.002). There were no significant differences in the overall survival among the three groups.
CONCLUSION: There was no metastasis to the lymph nodes around the common hepatic artery, and peritoneal dissemination was the most common site of recurrence in Pt tumors.

Entities:  

Keywords:  Distal pancreatectomy; Left-sided pancreas cancer; Pancreas cancer; Prognosis

Year:  2020        PMID: 32970195     DOI: 10.1007/s00595-020-02151-y

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  3 in total

1.  Curative resection of pancreatic adenocarcinoma with major venous resection/repair is safe procedure but will not improve survival.

Authors:  Alireza Hamidian Jahromi; Elnaz Jafarimehr; Hany M Dabbous; Quyen Chu; Horacio D'Agostino; Runhua Shi; Gregory P Wellman; Gazi B Zibari; Hosein Shokouh-Amiri
Journal:  JOP       Date:  2014-09-28

Review 2.  Minimally invasive surgery for pancreatic cancer.

Authors:  Yoshihiro Miyasaka; Takao Ohtsuka; Masafumi Nakamura
Journal:  Surg Today       Date:  2020-08-28       Impact factor: 2.549

Review 3.  The past, present, and future status of multimodality treatment for resectable/borderline resectable pancreatic ductal adenocarcinoma.

Authors:  Tatsuma Sakaguchi; Sohei Satoi; Tomohisa Yamamoto; So Yamaki; Mitsugu Sekimoto
Journal:  Surg Today       Date:  2020-01-28       Impact factor: 2.549

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.